
Arterial.com reported|State Creative Synthetic Biology Platform Upgrade! Linking the upstream and downstream of the industry chain to solve the three major problems that hinder the industrialization of synthetic biology
Under the huge market capacity and rich application scenarios, synthetic biology has been standing at the high point of the industry in recent years. According to the incomplete statistics of Artery Orange database, in 2022, the